CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Chlordiazepoxide Hydrochloride And Clidinium Bromide patents expire, and when can generic versions of Chlordiazepoxide Hydrochloride And Clidinium Bromide launch?
Chlordiazepoxide Hydrochloride And Clidinium Bromide is a drug marketed by Alkem Labs Ltd, Amneal, Chartwell Rx, Corepharma, Dr Reddys, Micro Labs, Misemer, Nuvo Pharms Inc, and Teva Pharms Usa. and is included in nine NDAs.
The generic ingredient in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlordiazepoxide Hydrochloride And Clidinium Bromide
A generic version of CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE was approved as chlordiazepoxide hydrochloride; clidinium bromide by NUVO PHARMS INC on July 7th, 2020.
Summary for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 11 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE? | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE excipients list |
DailyMed Link: | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE at DailyMed |

Pharmacology for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Drug Class | Anticholinergic Benzodiazepine |
Mechanism of Action | Cholinergic Antagonists |
Physiological Effect | Decreased Parasympathetic Acetylcholine Activity Digestive/GI System Activity Alteration GI Motility Alteration |